Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis: Final Results

NCT01389401 is registered in ClinicalTrials.gov with Faculdade de Ciências Médicas da Santa Casa de São Paulo as lead sponsor.

NCT NCT01389401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01389401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis: Final Results
Lead sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2011
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic laryngitis, gastroesophageal reflux disease (gerd)